Physician profile
Caressa Chen
NPI 1063918050
$5,620.51
in general payments reported to CMS, 2019-2025
14 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.48 · 2022: $2,524 · 2023: $1,293 · 2024: $1,566 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,000 · Food and Beverage: $1,085.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,000.00 |
| Food and Beverage | $1,084.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,230.83 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Davol INC. | $287.33 | 2023-2025 | Phasix Mesh |
| Tela Bio, INC. | $232.54 | 2024 | Ovitex 2s |
| Polynovo North America LLC | $221.00 | 2022-2024 | Novosorb Btm |
| Kerecis Limited | $145.92 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Integra Lifesciences Corporation | $141.68 | 2022 | |
| Baxter Healthcare | $99.33 | 2022 | |
| Urgo Medical North America, LLC | $97.47 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Ethicon US, LLC | $69.14 | 2024 | Stratafix |
| Innovation Technologies INC | $37.44 | 2024 | Irrisept |
| W. L. Gore & Associates, INC. | $18.39 | 2023 | Propaten Bioactive Surface |
| Boston Scientific Corporation | $15.42 | 2023 | Spyglass Discover |
| Lemaitre Vascular, INC. | $12.54 | 2022 | |
| Medical Device Business Services, INC. | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caressa Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.